Cannabis Cultivation Day Rescheduled for 2026 Return

MCPIR and CfC bring cannabis cultivation day back to its pre-GreenTech slot for 2026, a move industry stakeholders suggest will better align educational initiatives with the actual growing season. By decoupling the event from the larger GreenTech exhibition schedule, organizers aim to refocus the spotlight squarely on cultivation techniques, botanical science, and the nuances of…

Read More

Avicanna Subsidiary SMGH Marks Major Australian Expansion

Avicanna’s subsidiary, Santa Marta Golden Hemp (SMGH), has officially executed its inaugural commercial export of medical cannabis products to the Australian market. This strategic move represents a pivotal expansion for the Toronto-based biopharmaceutical company as it continues to bolster its global footprint and establish a robust presence in the highly regulated, high-demand Australian medical cannabis…

Read More

Medical Cannabis Research Bias Found: ‘Reverse Spin’ Downplays Benefits

New Study Exposes ‘Reverse Spin Bias’ in Medical Cannabis Findings A significant new study reveals a hidden bias in medical cannabis research. This bias actively downplays positive findings. Researchers have identified a phenomenon called ‘reverse spin bias’. It appears in systematic reviews of medical cannabis for pain. This discovery impacts how we understand cannabis research….

Read More